Viewing Study NCT00646750


Ignite Creation Date: 2025-12-24 @ 5:14 PM
Ignite Modification Date: 2026-02-21 @ 5:57 AM
Study NCT ID: NCT00646750
Status: COMPLETED
Last Update Posted: 2016-02-15
First Post: 2008-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom
Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Z-BEAM View
None Autologous View
None Lymphoma View
None GELTAMO View